Free Trial

CNS Pharmaceuticals (CNSP) SEC Filings & 10K Form

CNS Pharmaceuticals logo
$0.82 0.00 (-0.01%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$0.83 +0.01 (+0.85%)
As of 04/17/2025 06:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent CNS Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/09/2025
2:32 PM
CNS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2025
4:11 PM
CNS Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/31/2025
4:12 PM
CNS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2025
4:17 PM
CNS Pharmaceuticals (Filer)
Form 424B5
03/20/2025
4:15 PM
CNS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2025
4:00 PM
CNS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2024
11:24 AM
CNS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
3:19 PM
CNS Pharmaceuticals (Filer)
Form DEFR14A
11/01/2024
8:00 AM
CNS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2024
3:15 PM
CNS Pharmaceuticals (Filer)
Form DEF 14A
10/24/2024
4:27 PM
CNS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2024
10:23 AM
CNS Pharmaceuticals (Filer)
Form 424B5
10/23/2024
7:02 AM
CNS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2024
4:24 PM
CNS Pharmaceuticals (Filer)
Form PRE 14A
09/12/2024
7:58 AM
CNS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
4:22 PM
CNS Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2024
6:30 AM
CNS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
4:11 PM
CNS Pharmaceuticals (Issuer)
Cortice Biosciences, Inc. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:53 PM
CNS Pharmaceuticals (Issuer)
Cortice Biosciences, Inc. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/04/2024
11:15 PM
CNS Pharmaceuticals (Filer)
Form EFFECT
07/31/2024
11:32 AM
CNS Pharmaceuticals (Filer)
Form RW
07/30/2024
4:13 PM
CNS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2024
4:15 PM
CNS Pharmaceuticals (Filer)
Form 424B3
07/30/2024
6:00 AM
CNS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2024
7:30 AM
CNS Pharmaceuticals (Filer)
Form 424B5
07/26/2024
7:00 AM
CNS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2024
8:30 AM
CNS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2024
4:12 PM
CNS Pharmaceuticals (Filer)
Form S-1/A
07/12/2024
3:30 PM
CNS Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
07/11/2024
6:38 PM
CNS Pharmaceuticals (Filer)
Form 8-K/A
07/09/2024
10:25 AM
CNS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/05/2024
8:49 AM
CNS Pharmaceuticals (Filer)
Form 424B5
07/03/2024
3:56 PM
CNS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2024
11:34 AM
CNS Pharmaceuticals (Subject)
Forster Robert (Filed by)
Form SC 13G
06/27/2024
9:00 AM
CNS Pharmaceuticals (Filer)
Form 424B5
06/26/2024
4:25 PM
CNS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
6:19 PM
CNS Pharmaceuticals (Subject)
Forster Robert (Filed by)
Form SC 13G
06/20/2024
4:00 PM
CNS Pharmaceuticals (Filer)
Form 8-K/A
06/17/2024
10:17 AM
CNS Pharmaceuticals (Filer)
Form 424B5
06/14/2024
4:25 PM
CNS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/19/2024
11:15 PM
CNS Pharmaceuticals (Filer)
Form EFFECT
Altucher: Turn $900 into $108,000 in just 12 months? (Ad)

We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.

If I’m right about this (like I was before) a modest $900 investment…
05/16/2024
9:56 AM
CNS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
4:00 PM
CNS Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2024
4:28 PM
CNS Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
05/07/2024
4:00 PM
CNS Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CNSP) was last updated on 4/20/2025 by MarketBeat.com Staff
From Our Partners